| 从“齐二药”事件谈我国药品监管法律制度的完善 |
| |
| 引用本文： | 李晓农.从“齐二药”事件谈我国药品监管法律制度的完善[J].中国卫生法制,2006(5). |
| |
| 作者姓名： | 李晓农 |
| |
| 作者单位： | 北京大学医学部卫生法学教研室 北京 |
| |
| 摘 要： | “齐二药”事件反映出我国在药品生产领域存在的问题,我国应该从法规制定、建立监管制度等各方面完善对制药企业的监督管理,确保药品质量安全。
|
| 关 键 词： | 监督管理 GMP 法规规章 |
Supervision System on Drug Manufacturing in China |
| |
| LI Xiaonong Medical law office,Peking university medical science center,Peking ,China.Supervision System on Drug Manufacturing in China[J].China Health Law,2006(5). |
| |
| Authors: | LI Xiaonong Medical law office Peking university medical science center Peking China |
| |
| Institution: | LI Xiaonong Medical law office,Peking university medical science center,Peking 100083,China |
| |
| Abstract: | The incident that patient dying resulting from false drug reflects many problems in this field.In order to ensure drug quality,we should consummate supervision system on drug manufacturing. |
| |
| Keywords: | supervision GMP statute |
| 本文献已被 CNKI 等数据库收录！ |
|
